Ajax-Loading

Astellas Pharma Inc. - Change To Liabilities

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-To-Liabilities" stands at 3.29 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 37.98 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 37.98 Billion Japanese Yens.
The 3 year change is 41.17 Billion Japanese Yens.
The 5 year change is -49.28 Billion Japanese Yens.

The Serie's long term average value is -11.97 Billion Japanese Yens. It's latest available value, on 12/31/2023, is 15.27 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2021, to it's latest available value, on 12/31/2023, is +54.86 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2018, to it's latest available value, on 12/31/2023, is -49.28 Billion.

Change To Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Change To Liabilities905,699,262,464.00
LogoJohnson & Johnson - Change To Liabilities486,508,953,600.00
LogoAbbVie Inc - Change To Liabilities399,570,305,024.00
LogoRoche Holding AG - Change To Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Change To Liabilities280,205,508,085.11